Yuhao Ba

801 total citations · 1 hit paper
33 papers, 402 citations indexed

About

Yuhao Ba is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yuhao Ba has authored 33 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Yuhao Ba's work include Cancer Cells and Metastasis (6 papers), Immune cells in cancer (6 papers) and Immunotherapy and Immune Responses (4 papers). Yuhao Ba is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Immune cells in cancer (6 papers) and Immunotherapy and Immune Responses (4 papers). Yuhao Ba collaborates with scholars based in China, United Kingdom and Ireland. Yuhao Ba's co-authors include Xinwei Han, Yuqing Ren, Yuyuan Zhang, Siyuan Weng, Shutong Liu, Quan Cheng, Zaoqu Liu, Anning Zuo, Zhaokai Zhou and Peng Luo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Yuhao Ba

29 papers receiving 398 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multi-stage mechanisms of tumor metastasis and therapeutic strategies

2024 54 citations Zaoqu Liu, Jingqi Chen et al. Signal Transduction and Targeted Therapy profile →

Peers

Yuhao Ba

MB

ONCOL

IMMUN

PRM

CR

Haiqin Yang China

Wentao Tian China

Shunda Wang China

Shu Tan China

Yuanhong Wu China

Yiran Yao China

Xi Cheng China

Premila D. Leiphrakpam United States

Philippe Huget Belgium

Johnny Yu United States

Haiqin Yang China

Yuhao Ba

103 ×0.7

MB

89 ×0.7

ONCOL

63 ×0.6

IMMUN

47 ×0.5

PRM

63 ×0.9

CR

Citations per year, relative to Yuhao Ba Yuhao Ba (= 1×) peers Haiqin Yang

Countries citing papers authored by Yuhao Ba

Since Specialization

Citations

This map shows the geographic impact of Yuhao Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhao Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhao Ba more than expected).

Fields of papers citing papers by Yuhao Ba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhao Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhao Ba. The network helps show where Yuhao Ba may publish in the future.

Co-authorship network of co-authors of Yuhao Ba

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhao Ba. A scholar is included among the top collaborators of Yuhao Ba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhao Ba. Yuhao Ba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Liu, Zaoqu, Yuhao Ba, Dan Shan, et al.. (2025). THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis. Cell Reports. 44(4). 115555–115555. 4 indexed citations

2.

Ren, Yuqing, Congying Yuan, Yuhao Ba, et al.. (2025). 3D Bioprinting for Engineering Organoids and Organ‐on‐a‐Chip: Developments and Applications. Medicinal Research Reviews. 45(6). 1630–1650. 5 indexed citations

3.

Ren, Yuqing, Anning Zuo, Shutong Liu, et al.. (2025). Cancer-associated fibroblasts drive lung adenocarcinoma progression via THBS2-mediated epithelial-mesenchymal transition. Oncogene. 44(44). 4284–4297.

4.

Liu, Shutong, Mei Kang, Yuqing Ren, et al.. (2025). The Interaction Between Vasculogenic Mimicry and the Immune System: Mechanistic Insights and Dual Exploration in Cancer Therapy. Cell Proliferation. 58(6). e13814–e13814. 5 indexed citations

5.

Shan, Dan, Yuqing Ren, Yuyuan Zhang, et al.. (2025). Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities. Cancer Communications. 45(5). 577–607. 5 indexed citations

6.

Liu, Zaoqu, Yuqing Ren, Jingqi Chen, et al.. (2025). Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate. Aging Cell. 24(2). e14467–e14467. 3 indexed citations

7.

Liu, Zaoqu, Jinhai Deng, Hui Xu, et al.. (2025). Efficient discovery of robust prognostic biomarkers and signatures in solid tumors. Cancer Letters. 613. 217502–217502. 2 indexed citations

8.

Liu, Long, Yuhao Ba, Yuyuan Zhang, et al.. (2025). FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axis. Theranostics. 15(10). 4593–4613. 6 indexed citations

9.

Wang, Ruizhi, Yudi Xu, Yuyuan Zhang, et al.. (2025). Total and regional fat-to-muscle mass ratio and risks of pan-cancer: a prospective cohort study. BMC Medicine. 23(1). 296–296. 1 indexed citations

10.

Pan, Teng, Yuyuan Zhang, Yushuai Wu, et al.. (2025). Cancer-associated fibroblasts enhance colorectal cancer lymphatic metastasis via CLEC11A/LGR5-mediated WNT pathway activation. Journal of Clinical Investigation. 135(20).

11.

Dang, Qin, Zhaokai Zhou, Shuang Chen, et al.. (2024). Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges. Cancer Medicine. 13(14). e70041–e70041. 5 indexed citations

12.

Zhou, Zhaokai, Jiaxin Xu, Shutong Liu, et al.. (2024). Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy. Biomarker Research. 12(1). 97–97. 15 indexed citations

13.

Zhou, Zhaokai, Yifeng Chen, Yuhao Ba, et al.. (2024). Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non‐Viral CAR‐NK Cell Engineering. Cell Proliferation. 58(4). e13791–e13791. 10 indexed citations

14.

Liu, Zaoqu, Jingqi Chen, Yuqing Ren, et al.. (2024). Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduction and Targeted Therapy. 9(1). 270–270. 54 indexed citations breakdown →

15.

Liu, Zaoqu, Zhaokai Zhou, Yuhao Ba, et al.. (2024). Targeting immunosenescence for improved tumor immunotherapy. SHILAP Revista de lepidopterología. 5(11). e777–e777. 13 indexed citations

16.

Xu, Yudi, Yuyuan Zhang, Yuhao Ba, et al.. (2024). Associations Between Cardiovascular Health (Life's Essential 8) and Mental Disorders. Clinical Cardiology. 47(9). e70019–e70019. 1 indexed citations

17.

Zhang, Yuyuan, Yuqing Ren, Yuhao Ba, et al.. (2024). Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application. Molecular Cancer. 23(1). 75–75. 38 indexed citations

18.

Chen, Zhuang, Yuhao Ba, Qin Dang, et al.. (2023). MPDZ is associated with immune infiltration and regulates migration and invasion by switching YAP1 phosphorylation in colorectal cancer. Cellular Signalling. 114. 110967–110967. 3 indexed citations

19.

Ren, Yuqing, Chunguang Guo, Yuyuan Zhang, et al.. (2023). Associations Between Life's Essential 8 and Chronic Kidney Disease. Journal of the American Heart Association. 12(24). e030564–e030564. 35 indexed citations

20.

Ge, Xiaoyong, Hui Xu, Siyuan Weng, et al.. (2023). Systematic analysis of transcriptome signature for improving outcomes in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 149(11). 8951–8968. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact